Skip to content

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03937817
Enrollment
300
Registered
2019-05-06
Start date
2019-09-25
Completion date
2029-03-31
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alpha and Beta Thalassemia, Human Physiology, Malaria, Sickle Cell Disease

Keywords

Assay Development, Malaria, Sickle Cell Disease, Alpha and Beta Thalassemia, Natural History

Brief summary

Background: Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need to collect biological samples from people with blood disorders. They also need to collect samples from healthy people. Objective: To collect samples to use for research on blood disorders. Eligibility: People ages 18-70 who have blood disorders. Healthy volunteers without blood disorders are also needed. Design: Participants will be screened with a medical history, physical exam, and blood and urine tests. Participants will give one or more samples. They will give them over 5 years. They can choose not to give any of the samples: Saliva: Participants will spit into a tube. They may also have the inside of their mouth swabbed. Urine: Participants will urinate into a cup. Blood and blood waste products: Blood will be taken through a needle in the participant s arm. Fat samples: An area on the participant s belly or buttock will be numbed. A small cut will be made into the skin and a small piece of fat removed. Mucus and cells from the lungs: The participant will be sedated. A flexible tube will be inserted through the nose or mouth into the lung airways. These participants will also have a physical exam, chest x-ray, and heart tests after the procedure.

Detailed description

The Physiology Unit of the Laboratory of Malaria and Vector Research studies the role of globin variants in erythroid and non-erythroid tissues. We hope to better understand the mechanism(s) through which alpha and beta globin variants impact malaria, sickle cell disease, or other diseases involving inflammation or vascular endothelial dysfunction. The collection of human specimens from healthy volunteers and patients with malaria, sickle cell disease, or other diseases involving inflammation or endothelial dysfunction is necessary for the development of laboratory and physiological assays to further basic and clinical research studies. This protocol defines the purposes for which specimens will be collected and establishes general conditions under which sample collection will be performed. Development of assays and our research into the roles of alpha and beta globin in normal human physiology, as well as in the pathogenesis of malaria and sickle cell disease, requires laboratory analysis of saliva/buccal swab, urine, blood, blood waste products, adipose tissue, bronchial brushing, and/or bronchoalveolar lavage specimens from human volunteers.

Interventions

None listed

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
Lead SponsorNIH

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* PARTICIPANT INCLUSION CRITERIA: 1. Aged 18-70 years. 2. Able to provide informed consent. 3. Willing to allow biological samples to be stored for future research. 4. Willing to provide one or more of the following tissues: saliva, urine, blood, blood waste products, adipose tissue, bronchial brushing, and/or BAL samples. 5. Willing to allow genetic testing on collected biological samples. PARTICIPANT

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Collect biological specimens (saliva, urine, blood, blood waste products, adipose tissue, bronchial brushing, and/or BAL)Throughout studyDevelopment and optimization of scientific assays and research of globin variants, sickle cell disease, malaria, or other related diseases.

Countries

United States

Contacts

CONTACTMary J Jackson, R.N.
alpha.study@nih.gov(301) 761-5667
CONTACTHans C Ackerman, M.D.
hans.ackerman@nih.gov(301) 761-5646
PRINCIPAL_INVESTIGATORHans C Ackerman, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026